ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across
North America, Asia, Europe and the Middle East
NEWPORT BEACH, Calif., Jan. 3, 2025 /PRNewswire/ -- CathWorks, a global leader in medical device digital health innovations, announced today the successful completion of enrollment of the Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment (ALL-RISE) randomized controlled trial (RCT). This landmark study represents a significant milestone in the field of interventional cardiology, evaluating the clinical and economic benefits of the CathWorks FFRangio® System in diagnosing and treating coronary artery disease (CAD), offering potentially groundbreaking evidence that could redefine the standard of care.
The ALL-RISE Study included over 1,924 patients across 59 sites in North America, Asia, Europe and the Middle East. Participants presenting with coronary stenoses of intermediate significance and requiring physiology assessment were randomized to receive either FFRangio-guided treatment or invasive pressure wire-guided treatment. Notably, this was the first-ever randomized controlled trial in the United States to assess clinical outcomes using an angiography-based tool for physiologic lesion assessment.
In a joint statement, the ALL-RISE Study Chair, Dr. Ajay J. Kirtane (NewYork-Presbyterian/Columbia University Irving Medical Center) and Principal Investigators, Dr. William Fearon (Stanford University) and Dr. Allen Jeremias (St. Francis Hospital & Heart Center), stated, "On behalf of the study executive committee, we would like to congratulate and thank all the global investigators, study coordinators and patients who collectively enabled this incredible accomplishment. The high level of engagement and record speed of enrollment parallel the growing adoption of FFRangio globally. We look forward to sharing the results of this landmark study after clinical follow-up is completed."
CathWorks Sr. Director of Clinical Affairs, Alex Froimovich M.D., added, "The completion of ALL-RISE enrollment marks a significant milestone for our company and team's mission to transform how cardiovascular disease is diagnosed and treated. We believe this study, adding to FFRangio's growing body of clinical evidence, has the potential to significantly advance the field of coronary physiology and close the gap between its current adoption and the appropriate use guidelines recommendations. FFRangio has already demonstrated higher diagnostic accuracy over all other angio-based technologies, highlighting the fact that not all angio-based technologies are created equal, and therefore technology-specific clinical data are needed."
Cardiovascular disease (CVD) remains the leading cause of death in the United States. According to the American Heart Association's (AHA) 2024 Heart Disease and Stroke Statistics Update, CVD accounted for 931,578 deaths in the U.S. in 2021, and close to 18 million deaths globally. Coronary artery disease (CAD) is the single largest contributor, responsible for over 40% of CV deaths. CathWorks believes the results from the ALL-RISE study will build on what the company refers to as a new era in physiology, underscoring FFRangio as the new standard of care with the potential to drive better patient outcomes while delivering tangible economic and resource utilization benefits to healthcare systems.
ABOUT CATHWORKS
CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio® System combines artificial intelligence and advanced computational science, transforming how cardiovascular disease is diagnosed and treated. The FFRangio System obtains physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. It provides physicians with quick and reliable intraprocedural FFRangio values for the entire coronary tree. For more information on CathWorks, visit www.cath.works and follow @CathWorks on LinkedIn.
Investors:
Mike Feher
mike.feher@cath.works
Media:
Sarita Monico
sarita.monico@cath.works
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial
NEW YORK, Jan. 5, 2025 /PRNewswire/ -- The leading charging solution brand TESSAN has launched a captivating documentary on YouTube featuring the talented singer-songwriter Rachael Yamagata sharing her creative experiences and personal journey. This documentary is a significant part of the collaborative initiative "What's Your Next Journey," where Rachael and TESSAN encourage people to discover and engage with the world around them.
The video offers an intimate glimpse into Rachael's world, exploring the profound connection between her travels and music. Watch it at: YOUTUBE-LINK.
Journey and Music Creation: Infusing Cultures into Melody
Rachael's journey is a testament to the power of travel as a source of inspiration and connection. Her experiences across the globe have enriched her life and infused her music with the vibrant colors and unique flavors of different cultures. For Rachael, travel is about more than just visiting new places; it is about forming meaningful connections with others. She believes that the essence of a journey lies in balancing the pursuit of dreams with the ability to savor the present moment.
Rachael shares, "Journey means a balance of a dream of where you're going and the ability to be in the present moment and to enjoy it, because that really is what your life is about. It's about that journey of experience of meeting new people, of seeing how you grow, and traveling is what does that for me. Experiencing new cultures, new ideas, new energies of the places I go."
Connection: Unmasking Authenticity Through Music
The documentary delves into the significance of connection in both music and life. Rachael explains, "Connection to me is about authentic relation with those around you, taking off the mask and realizing that we are in this together and in every way and picking up on all of the subtleties of what we don't always say. And having that courage to not judge, to have empathy, and to really feel like we can be honest with one another."
For Rachael, connection means being genuine, removing masks, and embracing empathy and inclusivity. Music serves as a powerful conduit for deep connections, allowing individuals to release emotions and experience a profound sense of unity. "I think the real connection that I love about music is another permission slip to just deep dive. You can be alone listening to music and feel this incredible release. Because it translates that emotion that's stuck in there, and the music does it, the lyrics do it, the concept of the... the journey arc of the song, all of it contributes to that feeling."
New Journey in 2025
Looking ahead, Rachael is set to embark on a new journey in 2025 with the release of a new album. This project represents the culmination of a creative process that involves writing, recording, and sharing her music with the world.
"I must complete that journey first, that journey of taking the ideas, writing the songs, recording them, mixing them, doing the artwork, releasing the album to the world," Rachael shares, "After that, we'll see what is intriguing. I think that's how you find the best journey, is some spark lights within you and tells you where to go next. And you just follow that, and you have a really great time."
The collaboration between Rachael Yamagata and TESSAN offers a fresh perspective for those passionate about travel and music. By merging these two worlds, they inspire people to explore the globe with renewed enthusiasm, creating more opportunities for resonance and exchange. This partnership exemplifies the power of collaboration in fostering connections and igniting the spirit of adventure.
About TESSAN
TESSAN, a trusted partner in charging solutions, is committed to enriching experiences both at home and during travel. The brand offers a wide array of products, including multifunctional power strips, travel adapters, wall extenders, and smart home devices. Supported by a robust R&D and production team, TESSAN develops innovative socket products for users across the globe. With the trust of over 20 million users, TESSAN empowers their journeys from home to every destination, promoting environmentally conscious electricity usage.
For more information, visit www.tessan.com or the TESSAN Amazon store, and follow TESSAN on Facebook, Instagram, and YouTube.
CONTACT: Derien Lin, +86-0756-2550031, derien@tessan.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
TESSAN and Rachael Yamagata Unveil a Musical Journey: Discover the World Through Song and Story
